


Healthcare Industry NewsFeed
HSMN NewsFeed - 20 Sep 2016
Zimmer Biomet Launches VANGUARD(R) Individualized Design Knee Replacement
Zimmer Biomet Launches VANGUARD(R) Individualized Design Knee Replacement
HSMN NewsFeed - 20 Sep 2016
Advanced Accelerator Applications Announces Revised EMA Review Timeline for Lutathera(R)
Advanced Accelerator Applications Announces Revised EMA Review Timeline for Lutathera(R)
HSMN NewsFeed - 20 Sep 2016
Lannett Announces Approval For Buprenorphine And Naloxone Sublingual Tablets, 2 mg/0.5 mg And 8 mg/2 mg
Lannett Announces Approval For Buprenorphine And Naloxone Sublingual Tablets, 2 mg/0.5 mg And 8 mg/2 mg
HSMN NewsFeed - 19 Sep 2016
FDA-Cleared Bed Linens Engineered to Reduce Development of Pressure Ulcers
FDA-Cleared Bed Linens Engineered to Reduce Development of Pressure Ulcers
HSMN NewsFeed - 19 Sep 2016
Medeon Biodesign Receives FDA 510(k) Clearance for Abclose(TM) - Laparoscopic Port Site Closure Device
Medeon Biodesign Receives FDA 510(k) Clearance for Abclose(TM) - Laparoscopic Port Site Closure Device
HSMN NewsFeed - 16 Sep 2016
First patient in Switzerland treated with Elekta’s Leksell Gamma Knife Icon
First patient in Switzerland treated with Elekta’s Leksell Gamma Knife Icon
HSMN NewsFeed - 15 Sep 2016
Varian Medical Systems Receives FDA 510(k) Clearance for Nexus DR Digital X-Ray Imaging System
Varian Medical Systems Receives FDA 510(k) Clearance for Nexus DR Digital X-Ray Imaging System
HSMN NewsFeed - 15 Sep 2016
Sofregen Medical Raises $6.2 Million in Series A Funding from Polaris Partners and Other Founding Investors
Sofregen Medical Raises $6.2 Million in Series A Funding from Polaris Partners and Other Founding Investors
HSMN NewsFeed - 15 Sep 2016
Zimmer Biomet Adds 3D Range-of-Motion Simulation Capability with Strategic Acquisition of Clinical Graphics
Zimmer Biomet Adds 3D Range-of-Motion Simulation Capability with Strategic Acquisition of Clinical Graphics
HSMN NewsFeed - 15 Sep 2016
Eyevensys Announces Series A Extension Bringing Total Capital Raised to €9 Million
Eyevensys Announces Series A Extension Bringing Total Capital Raised to €9 Million
HSMN NewsFeed - 14 Sep 2016
DS Biopharma Announces the Appointment of Dr. Markus Weissbach as Chief Operating Officer
DS Biopharma Announces the Appointment of Dr. Markus Weissbach as Chief Operating Officer
HSMN NewsFeed - 12 Sep 2016
Regeneron Announces Election of Bonnie Bassler, Ph.D., and Huda Zoghbi, M.D., to Board of Directors
Regeneron Announces Election of Bonnie Bassler, Ph.D., and Huda Zoghbi, M.D., to Board of Directors
HSMN NewsFeed - 12 Sep 2016
Karyopharm Appoints Humphrey A.R. Gardner MD, FCAP as Senior Vice President, Clinical Development
Karyopharm Appoints Humphrey A.R. Gardner MD, FCAP as Senior Vice President, Clinical Development
HSMN NewsFeed - 9 Sep 2016
BioVie's Lead Compound BIV201 Receives FDA Orphan-Drug Designation for the Treatment of Ascites
BioVie's Lead Compound BIV201 Receives FDA Orphan-Drug Designation for the Treatment of Ascites
HSMN NewsFeed - 9 Sep 2016
Berlin Heals Announces Closure of Second Round Funding for Novel Cardiac Microcurrent System
Berlin Heals Announces Closure of Second Round Funding for Novel Cardiac Microcurrent System
HSMN NewsFeed - 8 Sep 2016
Neuravi Announces European Launch of EmboTrap II Stent Retriever for the Treatment of Acute Stroke
Neuravi Announces European Launch of EmboTrap II Stent Retriever for the Treatment of Acute Stroke
HSMN NewsFeed - 7 Sep 2016
FDA Grants Special Designation to TAXIS Pharmaceuticals Experimental Antibiotic
FDA Grants Special Designation to TAXIS Pharmaceuticals Experimental Antibiotic
HSMN NewsFeed - 7 Sep 2016
FDA allows Phrixus’s IND for Carmeseal-MD(TM) (P-188 NF) in Duchenne muscular dystrophy (DMD)
FDA allows Phrixus’s IND for Carmeseal-MD(TM) (P-188 NF) in Duchenne muscular dystrophy (DMD)
